NCT03789656 An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge) Status COMPLETED Phase PHASE2
NCT03571594 A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers Status TERMINATED Phase PHASE1
NCT03548415 Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands Status COMPLETED Phase PHASE2
NCT03252353 Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly Status UNKNOWN Phase PHASE3
NCT03158090 The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research Status RECRUITING Phase N/A
NCT03045302 Assessment of BIM23B065, Given as Repeated Subcutaneous Injection in Subjects With Acromegaly Status TERMINATED Phase PHASE2
NCT02807233 Lanreotide Autogel 120 mg at Extended Dosing Intervals (>4 Weeks) in Acromegalic Subjects Status COMPLETED Phase N/A
NCT02698384 Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg Status TERMINATED Phase N/A